Active, not recruitingNot applicableNCT02354079

HYPOCHOL : A Genetically-based Strategy to Identify New Targets in Cholesterol Metabolism

Studying Hypobetalipoproteinemia

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Nantes University Hospital
Principal Investigator: Charlotte AUTHIER, Doctor
Health Care Centers of French Health Insurance in Saint-Nazaire
Intervention: hypobetalipoproteinemia genetic and genotypic screening(genetic)
Enrollment: 435 target
Eligibility: All sexes
Timeline: 2016 – 2032

Study locations (1)

CHU de Nantes, Nantes, France

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02354079 on ClinicalTrials.gov

← Back to all trials